Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2016 16:15 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics to Present at the J.P. Morgan 34th Annual Healthcare Conference on January 12th

TUCSON, Ariz., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at...
December 15, 2015 11:29 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Completes $109 Million Offering, Underwriters Exercise in Full Their Option to Purchase Additional Shares

TUCSON, Ariz., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced that it completed a public offering of 6,426,471 shares of common stock today at a previously...
December 09, 2015 22:46 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock

TUCSON, Ariz., Dec. 9, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 5,588,236 shares of its common stock at a...
December 08, 2015 16:01 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock

TUCSON, Ariz., Dec. 8, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of $80 million of shares of its common...
December 02, 2015 05:30 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Reports Positive Results From Pilot Study of Its Investigational ID/AST System and Blood Culture Assay Kit and Initiation of Trial to Support FDA Clearance

TUCSON, Ariz., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and Blood...
December 01, 2015 17:37 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015

TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at...
August 05, 2015 05:30 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015

TUCSON, Ariz., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
June 30, 2015 23:58 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture Assay

TUCSON, Ariz., June 30, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of the...
April 17, 2015 05:00 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Announces New Leadership Appointments

TUCSON, Ariz., April 17, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...
March 23, 2015 10:49 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Names Juan Martin as Head of Europe, Middle East and Africa

TUCSON, Ariz., March 23, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right